Expert services in mass spectrometry™

Français

Mass spectrometry services

SEE HOW OUR SERVICES HELP TO ACHIEVE YOUR GOALS

PUBLICATION LIST

Gautham Vivek Sridharan, Matthew D’Alessandro, Shyam Sundhar Bale, Vicky Bhagat, Hugo Gagnon, John M. Asara, Korkut Uygun, Martin L. Yarmush, and Nima Saeidi (2017). Multi-omic network-based interrogation of rat liver metabolism following gastric bypass surgery featuring SWATH proteomics. TECHNOLOGY, September 2017, Vol. 05, No. 03 : pp. 139-184

 

Ferland, Catherine & Parent, Alexandre & Saran, Neil & M. Ingelmo, Pablo & Lacasse, Anaïs & Marchand, Serge & Sarret, Philippe & Ouellet, Jean. (2017). Preoperative Norepinephrine Levels in Cerebrospinal Fluid and Plasma Correlate With Pain Intensity After Pediatric Spine Surgery. Spine Deformity. 5. 325-333. 10.1016/j.jspd.2017.03.012.

 

Pubmed link

 

Gendron D, Blais Lecours P, Lemay AM, Beaulieu MJ, Huppé CA, Lee-Gosselin A, Flamand N, Don A, Bissonnette E, Blanchet MR, Laplante M,  Bourgoin S,  Bossé Y and Marsolais D. A Phosphorylatable Sphingosine Analog Induces Airway Smooth Muscle Cytostasis and Reverses Airway Hyperresponsiveness in Experimental Asthma. Frontiers in pharmacology. 2017.

Direct link

 

Vigier S, Gagnon H, Bourgade K, Klarskov K, Fulop T and Vermette P. Composition and organization of the pancreatic extracellular matrix by combined methods of immunohistochemistry, proteomics and scanning electron microscopy. Current research in translational medicine. 2017.

ResearchGate link

 

Ly K, Essalmani R, Desjardins R, Seidah N, Day R. An unbiaised mass spectrometry approach identifies Glypican-3 as an interactor of Proprotein convertase Subtilisin/Kexin type 9 (PCSK9) and LDL Receptor in hepatocellular carcinoma cells. JBC. 2017.

Direct link

 

Savard M, Côté J, Tremblay L, Neugebauer W, Regoli D, Gariépy S, Hébert N, Gobeil F.

Safety and pharmacokinetics of a kinin B1 receptor peptide agonist produced with different counter-ions. Biol Chem. 2015 Dec 12.

pubmed

 

Duhamel M, Rodet F, Delhem N, Vanden Abeele F, Kobeissy F, Nataf S, Pays L, Desjardins R, Gagnon H, Wisztorski M, Fournier I, Day R, Salzet M.

Molecular consequences of proprotein convertase 1/3 inhibition in macrophages for application to cancer immunotherapy: a proteomic study.

Mol Cell Proteomics. 2015

pubmed

 

Semaan W, Desbiens L, Houde M, Labonté J, Gagnon H, Yamamoto D, Takai S, Laidlaw T, Bkaily G, Schwertani A, Pejler G, Levesque C, Desjardins R, Day R, D'Orléans-Juste P.

Chymase inhibitor-sensitive synthesis of endothelin-1 (1-31) by recombinant mouse mast cell protease 4 and human chymase.

Biochem Pharmacol. 2015

 pubmed

 

Parent AJ, Beaudet N, Daigle K, Sabbagh R, Sansoucy Y, Marchand S, Sarret P, Goffaux P.

Relationship between blood- and cerebrospinal fluid-bound neurotransmitter concentrations and conditioned pain modulation in pain-free and  chronic pain subjects.

J Pain. 2015

pubmed

 

Levesque C, Couture F, Kwiatkowska A, Desjardins R, Guérin B, Neugebauer WA, Day R.

PACE4 inhibitors and their peptidomimetic analogs block prostate cancer tumor progression through quiescence induction, increased apoptosis and impaired neovascularisation.

Oncotarget. 2015

pubmed

 

Kwiatkowska A, Couture F, Levesque C, Ly K, Desjardins R, Beauchemin S, Prahl A, Lammek B, Neugebauer W, Dory YL, Day R.

Design, synthesis, and structure-activity relationship studies of a potent PACE4 inhibitor.

J Med Chem. 2014

pubmed

 

Gagnon H, Beauchemin S, Kwiatkowska A, Couture F, D'Anjou F, Levesque C, Dufour F, Desbiens AR, Vaillancourt R, Bernard S, Desjardins R, Malouin F, Dory YL, Day R.

Optimization of furin inhibitors to protect against the activation of influenza hemagglutinin H5 and Shiga toxin.

J Med Chem. 2014

pubmed

 

Kay P, Wagner JR, Gagnon H, Day R, Klarskov K.

Modification of peptide and protein cysteine thiol groups by conjugation with a degradation product of ascorbate.

Chem Res Toxicol. 2013

pubmed

 

Longuespée R, Gagnon H, Boyon C, Strupat K, Dauly C, Kerdraon O, Ighodaro A, Desmons A, Dupuis J, Wisztorski M, Vinatier D, Fournier I, Day R, Salzet M.

Proteomic analyses of serous and endometrioid epithelial ovarian cancers - cases studies - molecular insights of a possible histological etiology of serous ovarian cancer.

Proteomics Clin Appl. 2013

pubmed

 

Levesque C, Fugère M, Kwiatkowska A, Couture F, Desjardins R, Routhier S, Moussette P, Prahl A, Lammek B, Appel JR, Houghten RA, D'Anjou F, Dory YL, Neugebauer W, Day R.

The Multi-Leu peptide inhibitor discriminates between PACE4 and furin and exhibits antiproliferative effects on prostate cancer cells.

J Med Chem. 2012

pubmed